US News & World Report publishes its 2026 Best Hospitals rankings with new regional specialty metrics

🎨 Image Prompt

A dramatic low-angle photograph inside a sleek modern hospital atrium at dawn, where a lone surgeon in scrubs stands at the end of a long glass-walled corridor, backlit by cool blue morning light streaming through floor-to-ceiling windows while warm amber fixtures glow overhead. Reflections in the polished floor mirror the corridor's sharp geometric lines, and subtle abstract bar-chart light patterns ripple across a frosted glass wall behind them, evoking data and rankings without any readable text. Shot with a 35mm lens at f/2.0, shallow depth of field, cinematic contrast between deep shadows and luminous highlights, muted teal-and-amber color grade. Editorial news photography style, quiet tension, prestige and institutional scale, no text, no logos, no watermarks.

Share

The 2026–2027 edition of U.S. News & World Report's Best Hospitals rankings is now live, and it looks markedly different from the lists that preceded it. The publisher has introduced four new regional specialty rankings — in cancer; cardiology, heart and vascular surgery; orthopedics; and rehabilitation — while substantially reworking how it weighs the data behind each placement. The shift, according to the organisation and the coverage accompanying the release, moves the emphasis further toward risk-adjusted patient outcomes and outpatient care, and away from several of the proxies that shaped earlier editions.

The result is a ranking system that, for the first time on this scale, allows patients to compare complex specialty care close to home rather than only at a handful of nationally recognised academic centres. Hospitals across the United States have spent the days since the release publicising their designations in press releases, local media coverage and fundraising material, and the new edition is already being used in strategic planning and regional competition.

A methodology overhaul built around outcomes

The most consequential change in the 2026–2027 cycle is not the addition of new categories but the reweighting of the data underneath them. U.S. News and the secondary coverage of the release repeatedly note that risk-adjusted patient outcomes — measures such as survival and complication rates — now carry greater statistical weight than in previous editions.

The clearest example comes in cardiology, heart and vascular surgery, where the ranking was overhauled so that outcomes now account for 80 percent of the score. In that specialty, measures including patient volume, nurse staffing and expert opinion were dropped entirely. That is a significant departure for a ranking system that, for much of its history, leaned on structural and reputational inputs alongside clinical results.

Across the wider methodology, U.S. News has expanded its use of outpatient data, reflecting the reality that much complex care — particularly in cancer and cardiology — increasingly begins, and sometimes ends, outside an inpatient bed. The organisation has also published a Q&A with one of the architects of the rankings explaining the reasoning behind the changes, with the discussion focused chiefly on methodology, the new regional specialties and what the revised measures are intended to capture.

The logic behind the shift is not difficult to trace. Volume and staffing are inputs; they describe a hospital's capacity to deliver care but not necessarily the results it achieves. Expert opinion, meanwhile, has long been criticised as a measure vulnerable to reputation effects that can lag years behind actual performance. By contrast, risk-adjusted outcomes speak more directly to what happens to patients. Whether the new weighting fully delivers on that promise is a separate question — risk adjustment is itself a contested statistical exercise — but the direction of travel is unambiguous.

Four new regional specialty rankings

Alongside the methodological changes, U.S. News has introduced four regional specialty rankings covering cancer; cardiology, heart and vascular surgery; orthopedics; and rehabilitation. These sit beneath the established national specialty rankings and the procedures and conditions ratings that have long been a feature of the list.

The purpose is practical. A patient facing a complex cancer diagnosis or a cardiac procedure may not be able to travel to a nationally ranked centre hundreds of miles away, and may not need to. The regional rankings are designed to identify strong options within a metropolitan area or state, giving patients and referring physicians a way to compare institutions that are genuinely accessible to them.

Early results illustrate how the new categories are being received. Johns Hopkins Hospital is ranked No. 1 in Maryland and in the Baltimore metropolitan area in all four of the new regional specialties — cancer; cardiology, heart and vascular surgery; orthopedics; and rehabilitation. UCSF Health reports being best in the San Francisco metropolitan area in cancer, cardiology/heart and vascular surgery, and orthopedics under the new regional system. UC San Diego Health announced placement on the Best Hospitals honor roll, ranking No. 1 in California and in San Diego, with national rankings in eight adult specialties.

Those announcements matter beyond institutional pride. Rankings of this kind influence where patients seek care, where referring clinicians send complex cases, and which systems can attract scarce specialist talent. For academic medical centres, a No. 1 regional designation in a high-profile specialty is a marketing asset that can be deployed for years.

The scale of the undertaking

The reach of the 2026–2027 edition is considerable. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. The specialty and procedures/conditions ratings draw on more than 800 million patient care records, according to the publisher.

That volume of data is what makes the methodological changes meaningful rather than cosmetic. When a ranking leans more heavily on outcomes, the underlying records must be deep enough and standardised enough to support comparison across institutions of very different sizes, missions and patient populations. Academic medical centres, for instance, often treat sicker and more complex patients than community hospitals, which is precisely why risk adjustment exists — and why its quality is the single most important technical question in any outcomes-based ranking.

U.S. News has not published, in the material available, a specialty-by-specialty breakdown of exactly how each measure is weighted outside the cardiology overhaul. Patients and analysts reading the list should therefore treat the methodology documentation, rather than the headline placements alone, as the primary source for understanding what each ranking does and does not capture.

Health systems move quickly to capitalise

Within days of the release, health systems were already translating their results into public messaging. As of September 15–16, 2026, organisations including Ardent Health Services and regional centres such as Lovelace Medical Center in New Mexico were issuing fresh press releases highlighting Best Regional Hospital designations, regional specialty placements and "High Performing" badges in the procedures and conditions categories.

This is a familiar rhythm in American health care. Rankings season produces a wave of institutional communications, and the new regional specialties give far more hospitals something concrete to announce than the national rankings alone ever could. A community or regional hospital that would never appear in a national top-20 list can now claim a meaningful regional specialty designation, and the marketing value of that designation is real.

The flip side is that the expanded list also expands the pool of hospitals competing on the same terrain. In metropolitan areas where several systems can credibly claim strength in orthopedics or cardiology, the regional rankings sharpen a competition that is already intense — over patients, over surgeons, and over the payer contracts that follow reputation.

Why the changes matter for patients

For patients, the practical value of the 2026–2027 edition depends on how they use it. The rankings are not a referral service, and they do not account for individual circumstances: a patient's specific diagnosis, insurance network, travel capacity and physician relationships will often matter more than a hospital's placement in a specialty list.

What the regional specialties do offer is a starting point. A patient in New Mexico, Maryland or the Bay Area can now look at how institutions within reasonable travelling distance compare in cancer care or cardiac surgery, rather than being presented only with a national hierarchy that may be irrelevant to their situation. The heavier weighting on outcomes, if the underlying measures hold up, gives that comparison more clinical substance than a ranking built substantially on reputation and volume.

There is also a signalling effect on hospitals themselves. When rankings reward measured outcomes, institutions have an incentive to invest in the data infrastructure — registries, standardised reporting, quality improvement teams — needed to perform well on them. That can produce genuine improvements in care, though it can also produce measurement-driven distortions, a risk that has accompanied every generation of health care metrics.

The counterarguments and the limits of the data

Hospital rankings have long attracted criticism, and the 2026–2027 changes are unlikely to settle that debate. Three concerns recur in discussions of rankings of this kind, and each applies to the new edition.

The first is risk adjustment. Comparing mortality and complication rates across hospitals requires statistical correction for how sick patients were on arrival. If that adjustment is imperfect — and it always is, to some degree — hospitals that treat the most complex cases can appear worse than they are, and those that treat healthier populations can appear better. The decision to increase the weight on outcomes, and to make outcomes 80 percent of the cardiology score, raises rather than lowers the stakes on this question.

The second is data completeness and comparability. Rankings that draw on hundreds of millions of patient records depend on hospitals reporting consistently. Differences in coding practice, registry participation and data definitions can shape results in ways that have little to do with the quality of care delivered at the bedside.

The third is the gap between ranking and relevance. A hospital ranked highly in a specialty overall may not be the best choice for a particular condition, surgeon or treatment pathway. Rankings aggregate; patients are individuals.

U.S. News has addressed some of these issues directly through its methodology changes — dropping expert opinion and volume from cardiology, for instance, removes two frequently criticised inputs. But the trade-off is that the ranking now rests almost entirely on outcome measurement, and its credibility will rise or fall with the quality of that measurement.

What happens next

The 2026–2027 edition is now fully in effect, and the immediate next phase will be institutional. Health systems will fold their designations into advertising, physician recruitment and board reporting. Regional competitors will analyse where they lost ground and why. Quality teams will examine which measures moved their scores and which did not.

Longer term, the more consequential question is whether the shift toward outcomes and outpatient data becomes a durable feature of the rankings or the beginning of a broader restructuring. The expansion into outpatient care reflects where medicine is going: more procedures in ambulatory settings, more chronic disease management outside hospital walls, more care delivered in settings that traditional hospital rankings captured poorly or not at all. If U.S. News continues down that path, future editions could look substantially different again.

There is also the question of how the regional specialty rankings evolve. Four specialties is a limited set. Cancer, cardiology, orthopedics and rehabilitation represent a large share of complex care, but patients with neurological, gastrointestinal, pulmonary or other conditions still rely on the national specialty lists and the procedures and conditions ratings. Whether the regional model expands to additional specialties will be watched closely by hospitals that currently have nothing to promote at the regional level.

For now, the 2026–2027 rankings give patients something they have not had before at this scale: a way to assess complex specialty care within reach. Whether that translates into better decisions — and better care — depends on how carefully the underlying measures are read, and how honestly hospitals and clinicians use them. A ranking is a tool, not a verdict. The new edition sharpens the tool and points it closer to home; it does not remove the responsibility from the people using it.

Further Reading

← Back to News